Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 2
2017 2
2018 1
2019 1
2020 4
2021 6
2022 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Results by year

Filters applied: . Clear all
Page 1
Long-Term Oral Treatment with Non-Hypoglycemic Dose of Glibenclamide Reduces Diabetic Retinopathy Damage in the Goto-KakizakiRat Model.
Berdugo M, Delaunay K, Lebon C, Naud MC, Radet L, Zennaro L, Picard E, Daruich A, Beltrand J, Kermorvant-Duchemin E, Polak M, Crisanti P, Behar-Cohen FF. Berdugo M, et al. Among authors: delaunay k. Pharmaceutics. 2021 Jul 17;13(7):1095. doi: 10.3390/pharmaceutics13071095. Pharmaceutics. 2021. PMID: 34371786 Free PMC article.
Oral Ursodeoxycholic Acid Crosses the Blood Retinal Barrier in Patients with Retinal Detachment and Protects Against Retinal Degeneration in an Ex Vivo Model.
Daruich A, Jaworski T, Henry H, Zola M, Youale J, Parenti L, Naud MC, Delaunay K, Bertrand M, Berdugo M, Kowalczuk L, Boatright J, Picard E, Behar-Cohen F. Daruich A, et al. Among authors: delaunay k. Neurotherapeutics. 2021 Apr;18(2):1325-1338. doi: 10.1007/s13311-021-01009-6. Epub 2021 Feb 3. Neurotherapeutics. 2021. PMID: 33537951 Free PMC article.
The antidiabetic drug glibenclamide exerts direct retinal neuroprotection.
Berdugo M, Delaunay K, Naud MC, Guegan J, Moulin A, Savoldelli M, Picard E, Radet L, Jonet L, Djerada Z, Gozalo C, Daruich A, Beltrand J, Jeanny JC, Kermorvant-Duchemin E, Crisanti P, Polak M, Behar-Cohen F. Berdugo M, et al. Among authors: delaunay k. Transl Res. 2021 Mar;229:83-99. doi: 10.1016/j.trsl.2020.10.003. Epub 2020 Oct 17. Transl Res. 2021. PMID: 33080394 Free article.
[Macular edema: Understand mechanisms to develop treatments].
Behar-Cohen F, Zhao M, Gelize E, Bousquet E, Daruich A, Matet A, Delaunay K, Torriglia A, Berdugo-Polak M, Jaisser F, de Kozak Y, Lassiaz P. Behar-Cohen F, et al. Among authors: delaunay k. Med Sci (Paris). 2020 Aug-Sep;36(8-9):753-762. doi: 10.1051/medsci/2020130. Epub 2020 Aug 21. Med Sci (Paris). 2020. PMID: 32821052 Free article. Review. French.
Mechanisms of FH Protection Against Neovascular AMD.
Borras C, Delaunay K, Slaoui Y, Abache T, Jorieux S, Naud MC, Sanharawi ME, Gelize E, Lassiaz P, An N, Kowalczuk L, Ayassami C, Moulin A, Behar-Cohen F, Mascarelli F, Dinet V. Borras C, et al. Among authors: delaunay k. Front Immunol. 2020 Apr 3;11:443. doi: 10.3389/fimmu.2020.00443. eCollection 2020. Front Immunol. 2020. PMID: 32318056 Free PMC article.
16 results